● TIER 1 — FDA-approved / recognizedGRADE AMetabolic (other)
Teriparatide / Abaloparatide
PTH/PTHrP analogs. Research verification: Yes (TGA pending). Origin: Japan. Citations verified: yes. 3 human study record(s) in the FitClinicMD studies database.
FDA status
Approved: Forteo, Tymlos.
Compounding (503A/503B)
Approved.
DEA
Not controlled.
WADA (sport)
Not listed on 2026 Prohibited List (no matching section found)
Mechanism
PTH1R anabolic.
Human evidence · 3
ACTIVE, n=2,463. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
Nakamura T et al. TOWER trial. J Clin Endocrinol Metab 2012.
Trial Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
Reference only. This page summarizes publicly available regulatory and research information about Teriparatide / Abaloparatide. It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.